An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome

Clinical Immunology

Volumn 109, Issue 3, 2003, Pages 272-277

  Conley, Mary Ellen ^a,b   Saragoussi, Delphine ^c   Notarangelo, Luigi ^d   Etzioni, Amos ^e   Casanova, Jean Laurent ^c  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY OF BRESCIA   (Italy)

^e MEYER CHILDREN S HOSPITAL   (Israel)

Author keywords

Collaboration; Genotype; Immunologic deficiency syndromes; Intravenous immunoglobulins; Practice guidelines; Prophylaxis, antibiotic; Stem cell transplantation; Thrombocytopenia

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN; PENICILLIN G;

ARTICLE; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL EXAMINATION; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; STEM CELL TRANSPLANTATION; WISKOTT ALDRICH SYNDROME;

EID: 0347755106     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.08.005     Document Type: Article

References (30)

1. Wiskott A. Familiarer, angeborener Morbus Werlhofii? Monatsschrift Kinderheilkunde. 68:1937;212-216.
2. Aldrich R.A., Steinberg A.G., Campbell D.C. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 13:1954;133-139.
3. Perry G.S., Spector B.D., Schuman L.M., Mandel J.S., Anderson V.E., McHugh R.B., Hanson M.R., Fahlstrom S.M., Krivit W., Kersey J.H. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J.Pediatr. 97:1980;72-78.
4. Derry J.M.J., Ochs H.D., Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 78:1994;635-644.
5. Sullivan K.E., Mullen C.A., Blaese R.M., Winkelstein J.A. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J. Pediatr. 125:1994;876-885.
6. Derry J.M., Kerns J.A., Weinberg K.I., Ochs H.D., Volpini V., Estivill X., Walker A.P., Francke U. WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum. Mol. Genet. 4:1995;1127-1135.
7. Zhu Q., Watanabe C., Liu T., Hollenbaugh D., Blaese R.M., Kanner S.B., Aruffo A., Ochs H.D. Wiskott-Aldrich syndrome/X-linked thrombocytopenia WASP gene mutations, protein expression, and phenotype . Blood. 90:1997;2680-2689.
8. Notarangelo L.D., Mazza C., Giliani S., D'Aria C., Gandellini F., Ravelli C., Locatelli M.G., Nelson D.L., Ochs H.D., Notarangelo L.D. Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood. 99:2002;2268-2269.
9. Symons M., Derry J.M., Karlak B., Jiang S., Lemahieu V., Mccormick F., Francke U., Abo A. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell. 84:1996;723-734.
10. Aspenstrom P., Lindberg U., Hall A. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr. Biol. 6:1996;70-75.
11. Devriendt K., Kim A.S., Mathijs G., Frints S.G., Schwartz M., Van Oord Den J.J., Verhoef G.E., Boogaerts M.A., Fryns J.P., You D., Rosen M.K., Vandenberghe P. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat. Genet. 27:2001;313-317.
12. Lum L.G., Tubergen D.G., Corash L., Blaese R.M. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome. N. Engl. J. Med. 302:1980;892-896.
13. Mullen C.A., Anderson K.D., Blaese R.M. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome long-term follow-up of 62 cases . Blood. 82:1993;2961-2966.
14. Litzman J., Jones A., Hann I., Chapel H., Strobel S., Morgan G. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch. Dis. Child. 75:1996;436-439.
15. Ozsahin H., Le Deist F., Benkerrou M., Cavazzana-Calvo M., Gomez L., Griscelli C., Blanche S., Fischer A. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J. Pediatr. 129:1996;238-244.
16. Filipovich A.H., Stone J.V., Tomany S.C., Ireland M., Kollman C., Pelz C.J., Casper J.T., Cowan M.J., Edwards J.R., Fasth A., Gale R.P., Junker A., Kamani N.R., Loechelt B.J., et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program . Blood. 97:2001;1598-1603.
17. Mathew P., Conley M.E. Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott-Aldrich syndrome. Pediatr. Allergy Immunol. 6:1995;91-94.
18. Patel D.D., Gooding M.E., Parrott R.E., Curtis K.M., Haynes B.F., Buckley R.H. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N. Engl. J. Med. 342:2000;1325-1332.
19. Antoine C., Muller S., Cant A., Cavazzana-Calvo M., Veys P., Vossen J., Fasth A., Heilmann C., Wulffraat N., Seger R., Blanche S., Friedrich W., Abinun M., Davies G., et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 361:2003;553-560.
20. Bruton O.C. Agammaglobulinemia. Pediatrics. 9:1952;722-728.
21. Bernatowska E., Madalinski K., Janowicz W., Weremowicz R., Gutkowski P., Wolf H.M., Eibl M.M. Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatment. Clin. Immunol. Immunopathol. 43:1987;153-162.
22. Liese J.G., Wintergerst U., Tympner K.D., Belohradsky B.H. High- vs low-dose immunoglobulin therapy in the long-term treatment of X-linked agammaglobulinemia. Am. J. Dis. Child. 146:1992;335-339.
23. Quartier P., Debre M., De Blic J., de Sauverzac R., Sayegh N., Jabado N., Haddad E., Blanche S., Casanova J.L., Smith C.I., Le Deist F., de Saint B.G., Fischer A. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia a retrospective survey of 31 patients . J. Pediatr. 134:1999;589-596.
24. Moen R.C., Horowitz S.D., Sondel P.M., Borcherding W.R., Trigg M.E., Billing R., Hong R. Immunologic reconstitution after haploidentical bone marrow transplantation for immune deficiency disorders treatment of bone marrow cells with monoclonal antibody CT-2 and complement . Blood. 70:1987;664-669.
25. Wagner J.E., Rosenthal J., Sweetman R., Shu X.O., Davies S.M., Ramsay N.K., McGlave P.B., Sender L., Cairo M.S. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors analysis of engraftment and acute graft-versus-host disease . Blood. 88:1996;795-802.
26. R. F. Storb, R. Champlin, S. R. Riddell, M. Murata, S. Bryant, E. H. Warren, Non-myeloablative transplants for malignant disease, Hematology (Am. Soc. Hematol. Educ. Program) (2001) 375-391.
27. Gaspar H.B., Amrolia P., Hassan A., Webb D., Jones A., Sturt N., Vergani G., Pagliuca A., Mufti G., Hadzic N., Davies G., Veys P. Non-myeloablative stem cell transplantation for congenital immunodeficiencies. Recent Results Cancer Res. 159:2002;134-142.
28. Candotti F., Facchetti F., Blanzuoli L., Stewart D.M., Nelson D.L., Blaese R.M. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying "null" mutations. Gene Ther. 6:1999;1170-1174.
29. Huang M.M., Tsuboi S., Wong A., Yu X.J., Oh-Eda M., Derry J.M., Francke U., Fukuda M., Weinberg K.I., Kohn D.B. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins. Gene Ther. 7:2000;314-320.
30. Klein C., Nguyen D., Liu C.H., Mizoguchi A., Bhan A.K., Miki H., Takenawa T., Rosen F.S., Alt F.W., Mulligan R.C., Snapper S.B. Gene therapy for Wiskott-Aldrich syndrome rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice . Blood. 101:2003;2159-2166.